+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

North America Liquid Biopsy Market to 2027 - Regional Analysis and Forecasts by Product & Services; Sample; Application; End User; and, Country

  • ID: 5138191
  • Report
  • August 2020
  • Region: North America
  • 100 Pages
  • The Insight Partners
UP TO OFF
until Jun 30th 2022

FEATURED COMPANIES

  • Biocept, Inc
  • Bio-Rad Laboratories Inc.
  • Inivata Ltd
North America, the liquid biopsy market, is anticipated to reach US$ 3,531.44 Mn in 2027 from US$ 1,651.23 Mn in 2019. The market is projected to grow with a CAGR of 10.1% from 2019-2027.

The liquid biopsy market is growing primarily due to the increasing prevalence of cancer. Restraining factors, such as low sensitivity of liquid biopsy, is likely to damage the growth of the market in the coming years. On the other hand, increasing liquid biopsy due to growing application and advancements is expected to have a positive impact on the growth of the North American liquid biopsy market in the coming years.

Liquid biopsy is a revolutionary technology that is opening up various perspectives. The technology consists of isolation and detection of circulating tumor cells, circulating tumor DNA and exosomes, which provides genomic information of the cancer patients. Liquid biopsy are used in cancer diagnosis in order to study response or resistance to given treatments.

Liquid biopsy is a non-invasive diagnostic test that identifies various types of cancer. The increasing prevalence of cancer among population is leading to the growth of liquid biopsy market across the world. For instance, in Canada, cancer is the leading cause of death among population and it is witnessed to be a second-leading cause after heart diseases in the US. As per the American Cancer Society, Inc, approximately, 1.9 million new cancer cases and 693,000 cancer deaths were recorded in 2018, in Northern America. Prostate cancers are the most commonly diagnosed cancers among males in North America; however, breast cancers remains leading in females. Additionally, lung cancer remains the most common cause of death in both sexes. It is estimated that the number of new cases of cancer incidence is 439.2 per 100,000 men and women per year. Moreover, rapid change in lifestyle and consumption of alcohol and tobacco products are the factors increasing the incidences of cancer among the population. The largest potential market for liquid biopsy is a screening tool and testing the general asymptomatic population for different types of cancer.

Exosome Diagnostics Inc., Thermo Fisher Scientific Inc. and Bio-Rad Laboratories Inc. are among the major companies manufacturing liquid biopsy testing products to detect cancer. Therefore, increasing prevalence of cancer across the world is expected to drive the growth of the global liquid biopsy market during the forecast period.

In 2019, the reagents & kits segment accounted for the largest market share in the North American liquid biopsy market based on the product & services, and the similar segment is estimated to mark the highest CAGR in the market during the forecast period, owing to the availability of complete set of kits for liquid biopsy.

Moreover, in the United States, due to an increasing number of infected patients, healthcare professionals and leading organizations are distracting the flow of healthcare resources from research & development to primary care, which is slowing down the process of innovation. Furthermore, the pandemic spread is also preventing the clinical trials, drug development, and diagnostic industry in the US. For instance, California-based Lucence Diagnostics Pte Ltd., who develops liquid biopsy and has a known player in this industry, has been diverted now to manufacture kits for COVID-19.

Some of the significant primary and secondary sources for liquid biopsy included in the report are American Cancer Society (ACR), Centers For Disease Control And Prevention (CDC), Food and Drug Administration (FDA), International Diabetes Federation (IDF), and among others.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Biocept, Inc
  • Bio-Rad Laboratories Inc.
  • Inivata Ltd
1. Introduction
1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Liquid Biopsy Market - By Product & Service
1.3.2 North America Liquid Biopsy Market - By Sample
1.3.3 North America Liquid Biopsy Market - By Circulating Biomarker
1.3.4 North America Liquid Biopsy Market - By Application
1.3.5 North America Liquid Biopsy Market - By End User
1.3.6 North America Liquid Biopsy Market - By Country

2. North America Liquid Biopsy Market - Key Takeaways

3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. North America Liquid Biopsy Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America Liquid Biopsy Market - North America PEST Analysis
4.3 Expert Opinion

5. North America Liquid Biopsy - Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Increasing Prevalence of Cancer
5.2 Key Restraints
5.2.1 Low Sensitivity of Liquid Biopsy
5.3 Key Market Opportunities
5.3.1 Increasing Liquid Biopsy Due to Growing Application and Advancements
5.4 Future Trends
5.4.1 Consistent Launch of New Products
5.5 Impact Analysis

6. Liquid Biopsy Market - North America Analysis
6.1 North America Liquid Biopsy Market Revenue Forecasts and Analysis

7. Liquid Biopsy Market Analysis - By Product & Services
7.1 Overview
7.2 Liquid Biopsy Market Revenue Share, by Product& Service (2019 and 2027)
7.3 Equipment
7.3.1 Overview
7.4 Equipment: Liquid Biopsy Market - Revenue and Forecast to 2027 (US$ Million)
7.5 Reagents & Kits
7.5.1 Overview
7.5.2 Reagents & Kits: Liquid Biopsy Market - Revenue and Forecast to 2027 (US$ Million)
7.6 Services
7.6.1 Overview
7.6.2 Services: Liquid Biopsy Market - Revenue and Forecast to 2027 (US$ Million)

8. Liquid Biopsy Market Analysis - By Sample
8.1 Overview
8.2 Liquid Biopsy Market, by Sample, 2019 and 2027 (%)
8.3 Blood Based
8.3.1 Overview
8.3.2 Blood Based: Liquid Biopsy Market - Revenue and Forecast to 2027 (US$ Million)
8.4 Urine Based
8.4.1 Overview
8.4.2 Urine Based: Liquid Biopsy Market - Revenue and Forecast to 2027 (US$ Million)
8.5 Other Samples
8.5.1 Overview
8.6 Other Samples: Liquid Biopsy Market - Revenue and Forecast to 2027 (US$ Million)

9. Liquid Biopsy Market Analysis - By Circulating Biomarker
9.1 Overview
9.2 Liquid Biopsy Market, by Circulating Biomarker, 2019 and 2027 (%)
9.3 Circulating Tumor Cells (CTC)
9.3.1 Overview
9.3.2 Circulating Tumor Cell (CTC): Liquid Biopsy Market - Revenue and Forecast to 2027 (US$ Million)
9.4 Exosomes
9.4.1 Overview
9.4.2 Exosomes: Liquid Biopsy Market - Revenue and Forecast to 2027 (US$ Million)
9.5 Free Nucleic Acid
9.5.1 Overview
9.6 Free Nucleic Acid: Liquid Biopsy Market - Revenue and Forecast to 2027 (US$ Million)

10. Liquid Biopsy Market Analysis - By Application
10.1 Overview
10.2 Liquid Biopsy Market, by Application, 2019 and 2027 (%)
10.3 Non-invasive Prenatal Testing (NIPT)
10.3.1 Overview
10.3.2 Noninvasive prenatal testing (NIPT): Liquid Biopsy Market - Revenue and Forecast to 2027 (US$ Million)
10.4 Oncology
10.4.1 Overview
10.4.2 Oncology: Liquid Biopsy Market - Revenue and Forecast to 2027 (US$ Million)
10.5 Transplant Diagnostics
10.5.1 Overview
10.5.2 Transplant Diagnostics: Liquid Biopsy Market - Revenue and Forecast to 2027 (US$ Million)
10.6 Other Applications
10.6.1 Overview
10.7 Other applications: Liquid Biopsy Market - Revenue and Forecast to 2027 (US$ Million)

11. Liquid Biopsy Market Analysis - By End User
11.1 Overview
11.2 Liquid Biopsy Market, by End-User, 2019 and 2027 (%)
11.3 Academic & Research Institutes
11.3.1 Overview
11.3.2 Academic & Research Institutes: Liquid Biopsy Market - Revenue and Forecast to 2027 (US$ Million)
11.4 Hospitals
11.4.1 Overview
11.4.2 Hospitals: Liquid Biopsy Market - Revenue and Forecast to 2027 (US$ Million)
11.5 Reference Laboratories
11.5.1 Overview
11.6 Reference Laboratories: Liquid Biopsy Market - Revenue and Forecast to 2027 (US$ Million)
11.7 Other End Users
11.7.1 Overview
11.8 Other End Users: Liquid Biopsy Market - Revenue and Forecast to 2027 (US$ Million)

12. Liquid Biopsy Market Revenue and Forecasts To 2027 - Geographical Analysis
12.1 North America Liquid Biopsy Market Revenue and Forecasts To 2027
12.1.1 Overview
12.1.2 North America: Liquid Biopsy Market - Revenue and Forecast to 2027 (USD Million)
12.1.3 North America: Liquid Biopsy Market, by Product & Service, 2018-2027 (USD Million)
12.1.4 North America: Liquid Biopsy Market, by Sample, 2018-2027 (USD Million)
12.1.5 North America: Liquid Biopsy Market, by Circulating Biomarker, 2018-2027 (USD Million)
12.1.6 North America: Liquid Biopsy Market, by Application, 2018-2027 (USD Million)
12.1.7 North America: Liquid Biopsy Market, by End User, 2018-2027 (USD Million)
12.1.8 North America: Liquid Biopsy Market, by Country, 2019 & 2027 (%)
12.1.9 US: Liquid Biopsy Market - Revenue and Forecast to 2027 (USD Million)
12.1.9.1 US: Liquid Biopsy Market - Revenue and Forecast to 2027 (USD Million)
12.1.9.2 US: Liquid Biopsy Market, by Product & Service, 2018-2027 (USD Million)
12.1.9.3 US: Liquid Biopsy Market, by Sample, 2018-2027 (USD Million)
12.1.9.4 US: Liquid Biopsy Market, by Circulating Biomarker, 2018-2027 (USD Million)
12.1.9.5 US: Liquid Biopsy Market, by Application, 2018-2027 (USD Million)
12.1.9.6 US: Liquid Biopsy Market, by End User, 2018-2027 (USD Million)
12.1.10 Canada: Liquid Biopsy Market - Revenue and Forecast to 2027 (USD Million)
12.1.10.1 Canada: Liquid Biopsy Market - Revenue and Forecast to 2027 (USD Million)
12.1.10.2 Canada: Liquid Biopsy Market, by Product & Service, 2018-2027 (USD Million)
12.1.10.3 Canada: Liquid Biopsy Market, by Sample, 2018-2027 (USD Million)
12.1.10.4 Canada: Liquid Biopsy Market, by Circulating Biomarker, 2018-2027 (USD Million)
12.1.10.5 Canada: Liquid Biopsy Market, by Application, 2018-2027 (USD Million)
12.1.10.6 Canada: Liquid Biopsy Market, by End User, 2018-2027 (USD Million)
12.1.11 Mexico: Liquid Biopsy Market - Revenue and Forecast to 2027 (USD Million)
12.1.11.1 Mexico: Liquid Biopsy Market - Revenue and Forecast to 2027 (USD Million)
12.1.11.2 Mexico: Liquid Biopsy Market, by Product & Service, 2018-2027 (USD Million)
12.1.11.3 Mexico: Liquid Biopsy Market, by Sample, 2018-2027 (USD Million)
12.1.11.4 Mexico: Liquid Biopsy Market, by Circulating Biomarker, 2018-2027 (USD Million)
12.1.11.5 Mexico: Liquid Biopsy Market, by Application, 2018-2027 (USD Million)
12.1.11.6 Mexico: Liquid Biopsy Market, by End User, 2018-2027 (USD Million)

13. Impact of COVID-19 Pandemic on Global Liquid Biopsy Market
13.1 North America: Impact Assessment of COVID-19 Pandemic

14. Company Profiles
14.1 Thermo Fisher Scientific Inc.
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Bio-Rad Laboratories Inc.
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Exact Sciences Corporation
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 ey Developments
14.4 Biocept, Inc.
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Inivata Ltd
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments

15. Appendix
15.1 About the Publisher
15.2 Glossary of Terms
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Thermo Fisher Scientific Inc.
  • Bio-Rad Laboratories Inc.
  • Exact Sciences Corporation
  • Biocept, Inc
  • Inivata Ltd
Note: Product cover images may vary from those shown
Adroll
adroll